Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

5-Fluorouracil as a Tumor-Treating Field-Sensitizer in Colon Cancer Therapy.

Lee YJ, Cho JM, Sai S, Oh JY, Park JA, Oh SJ, Park M, Kwon J, Shin US, Beak JH, Lim SH, Song JY, Hwang SG, Kim EH.

Cancers (Basel). 2019 Dec 12;11(12). pii: E1999. doi: 10.3390/cancers11121999.

2.

A Small Compound KJ-28d Enhances the Sensitivity of Non-Small Cell Lung Cancer to Radio- and Chemotherapy.

Ryu H, Kim HJ, Song JY, Hwang SG, Kim JS, Kim J, Bui THN, Choi HK, Ahn J.

Int J Mol Sci. 2019 Nov 29;20(23). pii: E6026. doi: 10.3390/ijms20236026.

3.

A new FGFR inhibitor disrupts the TGF-β1-induced fibrotic process.

Kim MH, Jung SY, Song KH, Park JI, Ahn J, Kim EH, Park JK, Hwang SG, Woo HJ, Song JY.

J Cell Mol Med. 2020 Jan;24(1):830-840. doi: 10.1111/jcmm.14793. Epub 2019 Nov 6.

4.

Antitumor Activity of a Novel Tyrosine Kinase Inhibitor AIU2001 Due to Abrogation of the DNA Damage Repair in Non-Small Cell Lung Cancer Cells.

Ryu H, Choi HK, Kim HJ, Kim AY, Song JY, Hwang SG, Kim JS, Kim DU, Kim EH, Kim J, Ahn J.

Int J Mol Sci. 2019 Sep 24;20(19). pii: E4728. doi: 10.3390/ijms20194728.

5.

Tumor-Treating Fields Induce RAW264.7 Macrophage Activation Via NK-κB/MAPK Signaling Pathways.

Park JI, Song KH, Jung SY, Ahn J, Hwang SG, Kim J, Kim EH, Song JY.

Technol Cancer Res Treat. 2019 Jan 1;18:1533033819868225. doi: 10.1177/1533033819868225.

6.

Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells.

Kim EH, Jo Y, Sai S, Park MJ, Kim JY, Kim JS, Lee YJ, Cho JM, Kwak SY, Baek JH, Jeong YK, Song JY, Yoon M, Hwang SG.

Oncogene. 2019 Sep;38(39):6630-6646. doi: 10.1038/s41388-019-0882-7. Epub 2019 Aug 2.

PMID:
31375748
7.

Radiosensitizing Effect of Novel Phenylpyrimidine Derivatives on Human Lung Cancer Cells via Cell Cycle Perturbation.

Jung SY, Nam KY, Park JI, Song KH, Ahn J, Park JK, Um HD, Hwang SG, Choi SU, Song JY.

J Pharmacol Exp Ther. 2019 Sep;370(3):514-527. doi: 10.1124/jpet.119.257717. Epub 2019 Jun 28.

PMID:
31253693
8.

Inhibition of Karyopherin-α2 Augments Radiation-Induced Cell Death by Perturbing BRCA1-Mediated DNA Repair.

Song KH, Jung SY, Park JI, Ahn J, Park JK, Um HD, Park IC, Hwang SG, Ha H, Song JY.

Int J Mol Sci. 2019 Jun 11;20(11). pii: E2843. doi: 10.3390/ijms20112843.

9.

β-Apopicropodophyllin functions as a radiosensitizer targeting ER stress in non-small cell lung cancer.

Kim JY, Cho JH, Kim EM, Shin HJ, Hwang SG, Song JY, Um HD, Park JK.

Biomed Pharmacother. 2019 May;113:108769. doi: 10.1016/j.biopha.2019.108769. Epub 2019 Mar 11.

10.

PLOD3 suppression exerts an anti-tumor effect on human lung cancer cells by modulating the PKC-delta signaling pathway.

Baek JH, Yun HS, Kwon GT, Lee J, Kim JY, Jo Y, Cho JM, Lee CW, Song JY, Ahn J, Kim JS, Kim EH, Hwang SG.

Cell Death Dis. 2019 Feb 15;10(3):156. doi: 10.1038/s41419-019-1405-8.

11.

Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy.

Jo Y, Kim EH, Sai S, Kim JS, Cho JM, Kim H, Baek JH, Kim JY, Hwang SG, Yoon M.

Int J Mol Sci. 2018 Nov 21;19(11). pii: E3684. doi: 10.3390/ijms19113684.

12.

PLOD3 promotes lung metastasis via regulation of STAT3.

Baek JH, Yun HS, Kwon GT, Kim JY, Lee CW, Song JY, Um HD, Kang CM, Park JK, Kim JS, Kim EH, Hwang SG.

Cell Death Dis. 2018 Nov 15;9(12):1138. doi: 10.1038/s41419-018-1186-5.

13.

Selective toxicity of tumor treating fields to melanoma: an in vitro and in vivo study.

Jo Y, Hwang SG, Jin YB, Sung J, Jeong YK, Baek JH, Cho JM, Kim EH, Yoon M.

Cell Death Discov. 2018 Oct 3;4:46. doi: 10.1038/s41420-018-0106-x. eCollection 2018. Erratum in: Cell Death Discov. 2019 Jul 10;5:116.

14.

A novel anti-cancer role of β-apopicropodophyllin against non-small cell lung cancer cells.

Kim JY, Cho JH, Choi JR, Shin HJ, Song JY, Hwang SG, Um HD, Yoo YD, Kim J, Park JK.

Toxicol Appl Pharmacol. 2018 Oct 15;357:39-49. doi: 10.1016/j.taap.2018.08.022. Epub 2018 Aug 29.

PMID:
30170025
15.

MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cells.

Yoon YN, Choe MH, Jung KY, Hwang SG, Oh JS, Kim JS.

BMC Cancer. 2018 Jul 5;18(1):716. doi: 10.1186/s12885-018-4600-6.

16.

Centrosome Clustering Is a Tumor-selective Target for the Improvement of Radiotherapy in Breast Cancer Cells.

Choe MH, Kim J, Ahn J, Hwang SG, Oh JS, Kim JS.

Anticancer Res. 2018 Jun;38(6):3393-3400. doi: 10.21873/anticanres.12606.

PMID:
29848688
17.

miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP.

Choe MH, Yoon Y, Kim J, Hwang SG, Han YH, Kim JS.

Cell Death Dis. 2018 May 29;9(6):640. doi: 10.1038/s41419-018-0698-3.

18.

Kinesin light chain-4 depletion induces apoptosis of radioresistant cancer cells by mitochondrial dysfunction via calcium ion influx.

Baek JH, Lee J, Yun HS, Lee CW, Song JY, Um HD, Park JK, Park IC, Kim JS, Kim EH, Hwang SG.

Cell Death Dis. 2018 May 1;9(5):496. doi: 10.1038/s41419-018-0549-2.

19.

Knockdown of end-binding protein 1 induces apoptosis in radioresistant A549 lung cancer cells via p38 kinase-dependent COX-2 upregulation.

Baek JH, Yim JH, Song JY, Um HD, Park JK, Park IC, Kim JS, Lee CW, Hong EH, Kim EH, Hwang SG.

Oncol Rep. 2018 Apr;39(4):1565-1572. doi: 10.3892/or.2018.6278. Epub 2018 Feb 22.

PMID:
29484424
20.

AMRI-59 functions as a radiosensitizer via peroxiredoxin I-targeted ROS accumulation and apoptotic cell death induction.

Hong WG, Kim JY, Cho JH, Hwang SG, Song JY, Lee E, Chang TS, Um HD, Park JK.

Oncotarget. 2017 Dec 9;8(69):114050-114064. doi: 10.18632/oncotarget.23114. eCollection 2017 Dec 26.

Supplemental Content

Loading ...
Support Center